KIDS vs. ATRI, CSII, OSUR, CERS, TCMD, NARI, ICUI, IART, NVCR, and UFPT
Should you be buying OrthoPediatrics stock or one of its competitors? The main competitors of OrthoPediatrics include Atrion (ATRI), Cardiovascular Systems (CSII), OraSure Technologies (OSUR), Cerus (CERS), Tactile Systems Technology (TCMD), Inari Medical (NARI), ICU Medical (ICUI), Integra LifeSciences (IART), NovoCure (NVCR), and UFP Technologies (UFPT). These companies are all part of the "surgical & medical instruments" industry.
OrthoPediatrics (NASDAQ:KIDS) and Atrion (NASDAQ:ATRI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk, community ranking and valuation.
OrthoPediatrics presently has a consensus price target of $45.50, suggesting a potential upside of 55.29%. Given OrthoPediatrics' higher possible upside, equities analysts clearly believe OrthoPediatrics is more favorable than Atrion.
In the previous week, Atrion had 2 more articles in the media than OrthoPediatrics. MarketBeat recorded 3 mentions for Atrion and 1 mentions for OrthoPediatrics. Atrion's average media sentiment score of 1.08 beat OrthoPediatrics' score of 0.00 indicating that Atrion is being referred to more favorably in the news media.
OrthoPediatrics received 177 more outperform votes than Atrion when rated by MarketBeat users. Likewise, 64.56% of users gave OrthoPediatrics an outperform vote while only 54.66% of users gave Atrion an outperform vote.
Atrion has a net margin of 10.60% compared to OrthoPediatrics' net margin of -13.58%. Atrion's return on equity of 7.75% beat OrthoPediatrics' return on equity.
OrthoPediatrics has a beta of 1.18, suggesting that its stock price is 18% more volatile than the S&P 500. Comparatively, Atrion has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500.
Atrion has higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Atrion, indicating that it is currently the more affordable of the two stocks.
69.1% of OrthoPediatrics shares are held by institutional investors. Comparatively, 66.2% of Atrion shares are held by institutional investors. 31.8% of OrthoPediatrics shares are held by insiders. Comparatively, 22.8% of Atrion shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
Atrion beats OrthoPediatrics on 10 of the 17 factors compared between the two stocks.
Get OrthoPediatrics News Delivered to You Automatically
Sign up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding KIDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
OrthoPediatrics Competitors List
Related Companies and Tools
